Inclusion body myositis: Status 1997

Neurologist

Volumn 3, Issue 4, 1997, Pages 201-208

  Karpati, George ^a,b  

^a MCGILL UNIVERSITY   (Canada)

^b NONE   (Canada)

Author keywords

Diagnosis; Inclusion body myositis; Pathophysiology; Treatment

Indexed keywords

EID: 0000552274     PISSN: 10747931     EISSN: None     Source Type: Journal    
DOI: 10.1097/00127893-199707000-00003     Document Type: Article

References (42)

1. Yunis EJ, Samaha FJ. Inclusion body myositis. Lab Invest 1997;25: 240-8.
2. Chou S-M. Myxovirus-like structures in a case of human chronic polymyositis. Science 1967;158:1453-5.
3. Chou S-M. Myxovirus-like structures and accompanying nuclear changes in chronic polymyositis. Arch Pathol Lab Med 1968;649-58.
4. Sato T, Walker DL, Peters HA, Reese HH, Chou S-M. Chronic polymyositis and myxovirus-like inclusions: Electron microscopic and viral studies. Arch Neurol 1971;24:409-18.
5. Carpenter S, Karpati G, Wolfe L. Virus-like filaments and phospholipid accumulation in skeletal muscle: Study of a histochemically distinct chronic myopathy. Neurology 1970;20:889-903.
6. Carpenter S, Karpati G, Heller I, Eisen A. Inclusion body myositis: A distinct variety of idiopathic inflammatory myopathy. Neurology 1978;28:8-17.
7. Lotz BP, Engel AG, Bishino H, Stevens JC, Litchy WJ. Inclusion body myositis: Observations in 40 patients. Brain 1989;112:727-47.
8. Dalakas MC. Polymyositis, dermatomyositis, and inclusion body myositis. N Engl J Med 1991;325:1487-98.
9. Karpati G, Carpenter S. Pathology of the inflammatory myopathies. Baillieres Clin Neurol 1993;2:527-56.
10. Massa R, Weller B, Karpati G, Shoubridge E, Carpenter S. Familial inclusion body myositis among Kurdish-Iranian Jews. Arch Neurol 1991;48:519-22.
11. Argov Z, Yarom R. "Rimmed vacuole myopathy" sparing the quadriceps: A unique disorder in Iranian Jews. J Neurol Sci 1984;64:33-43.
12. Sadeh M, Gadoth N, Hadar H, Ben-David E. Vacuolar myopathy sparing the quadriceps. Brain 1993;116:217-32.
13. Neville HE, Baumbach LL, Ringel SP, Russo LS Jr, Sujansky E, Garcia CA. Familial inclusion body myositis: Evidence for autosomal dominant inheritance. Neurology 1992;42:897-902.
14. Cole AJ, Kuzniecky R, Karpati G, Carpenter S, Anderman E, Anderman F. Familial myopathy with changes resembling inclusion body myositis and preventricular leucoencephalopathy. Brain 1988; 111:1025-37.
15. Sivakumar K, Dalakas MC. The spectrum of familial inclusion body myopathies in 13 families and a description of a quadriceps-sparing phenotype in non-Iranian Jews. Neurology 1996;47:977-84.
16. Carpenter S. Inclusion body myositis. J Neuropathol Exp Neurol 1996;55:1103-14.
17. Amato AA, Gronseth GS, Jackson CE, Wolfe GI, Katz JS, Bryan WW, et al. Inclusion body myositis: Clinical and pathological boundaries. Ann Neurol 1996;40:581-3.
18. Griggs RC, Askanas V, DiMauro S, Engel A, Karpati G, Mendell JR, et al. Inclusion body myositis and myopathies. Ann Neurol 1995; 38:705-13.
19. Hentati F, Ben Hamida C, Tome F, Oueslati S, Fardeau M, Ben Hamida M. "Familial inclusion body myositis" sparing the quadriceps with asymptomatic leukoencephalopathy in a Tunisian kindred [abstract]. Neurology 1991;41(Supl1):422.
20. Nonaka I, Nobuhiko S, Ishiura S, Satoyoshi E. Familial distal myopathy with rimmed vacuole and lamellar (myeloid) body formation. J Neurol Sci 1981;51:141-55.
21. Fardeau M, Askanas V, Tome FMS, Engel WK, Alvarez RB, McFerrin J, et al. Hereditary neuromuscular disorder with inclusion-body-myositis-like filamentous inclusion: Clinical, pathological, and tissue culture studies [abstract]. Neurology 1990;40:120.
22. indberg C, Edstrom BK, Hedstrom A, Oldfors A. Inclusion body myositis and Welander distal myopathy: A clinical, neurophysiological and morphological comparison. J Neurol Sci 1991;103:76-81.
23. McKee D, Karpati G, Johnston W, Carpenter S. Familial inclusion body myositis (IBM) mimics facioscapulohumeral dystrophy (FSHD). Neurology 1992;42:302.
24. Mitrani-Rosenbaum S, Argov Z, Blumenfeld A, Seidman CE, Seidman JG. Hereditary inclusion body myopathy maps to chromosome 9p1-q1. Hum Mol Genet 1996;5:159-63.
25. Karpati G, Carpenter S. Pathology of the inflammatory myopathies. Baillieres Clin Neurol 1993;2:527-56.
26. Askanas V, Engel WK, Dilak M, Alvarez RB, Selkoe DJ. Twisted tubulofilaments of inclusion-body myositis muscle resemble paired helical filaments of Alzheimer brain containing hyperphosphorylated tau. Am J Pathol 1994;144:177-87.
27. Askanas V. Engel WK, Alvarez RB. Enhanced detection of Congo-red-positive amyloid deposits in muscle fibers of inclusion body myositis and brain of Alzheimer disease using fluorescence technique. Neurology 1993;43:1265-7.
28. Debleecker JL, Ertl DB, Engel AG. Patterns of abnormal protein expression in target formations and unstructured cores. Neuromusc Disord 1996;6:339-49.
29. Askanas V, Engel WK. New advances in the understanding of sporadic inclusion body myopathies. Curr Opin Rheum 1995;7:486-96.
30. Nalbantoglu J, Karpati G, Carpenter S. Conspicuous accumulation of a single-stranded DNA binding protein in skeletal muscle fibers in inclusion body myositis. Am J Pathol 1994;144:874-82.
31. Pruit JN II, Showalter CJ, Engel AG. Sporadic inclusion body myositis: Counts of different types of abnormal fibers. Ann Neurol 1996; 39:139-43.
32. Karpati G, Pouliot Y, Carpenter S. Expression of immunoreactive major histocompatibility complex products in human skeletal muscles. Ann Neurol 1988;23:64-72.
33. Karpati G, Carpenter S. Evolving concepts about inclusion body myositis. In: Serratrice G, Pellesier JF, Pouget J, Blin O, Branger D, Turc F, et al., eds. Actualités neuromusculaires: Acquisition récentes. Paris: Exp Scient Française, 1993:93-8.
34. Oldfors A, Larsson NG, Lindberg C, Holme E. Mitochondrial DNA deletions in inclusion body myositis. Brain 1993;116:325-36.
35. Santorelli FM, Sciacco M, Tanji K, Shanske S, Vu TH, Golzi V, et al. Multiple mitochondrial DNA deletions in sporadic inclusion body myositis: A study of 56 patients. Ann Neurol 1996;39:789-95.
36. Johnston W, Karpati G, Carpenter S, et al. Late-onset mitochondrial myopathy. Ann Neurol 1995;37:16-23.
37. Verma A, Bradley WG, Soule NW, Pendleberry WW, Kelly J, Adelman LS, et al. Quantitative morphometric study of muscle in inclusion body myositis. J Neurol Sci 1992;112:192-8.
38. Berezney R. The nuclear matrix: A heuristic model for investigating genomic organization and function in the cell nucleus. J Cell Biochem 1991;47:109-23.
39. Getzenberg RH, Pienta KJ, Ward WS, Coffey DS. Nuclear structure and the three-dimensional organization of DNA. J Cell Biochem 1991;47:289-99.
40. Stuurman N, de Jong L, van Driel R. Nuclear frameworks: Concepts and operational definitions. Cell Biol Int Rep 1992;16:837-52.
41. Leff RL, Miller FW, Hicks J, Fraser DD, Plotz PH. The treatment of inclusion body myositis: A retrospective review and a randomized, prospective trial of immunosuppressive therapy. Medicine 1993;72: 225-35.
42. Dalakas MC. Uptake on the use of intravenous immune globulin in the treatment of patients with inflammatory muscle disease. J Clin Immunol 1995;15(Suppl):705-55.